CD4+ regulatory T cells (Tregs), as a kind of immunomodulatory cells, can interact with multiple immune cells to play roles in alleviating the inflammatory response after stroke and protecting the blood–brain barrier [5, 6]. This evidence concerns the gene CD4 and stroke disorder.